The FDA is looking for companies to participate in its quality-by-design (QbD) pilot program for biotechnology submissions, which is intended to help the agency develop guidance on the topic.
The FDA is looking for companies to participate in its quality-by-design (QbD) pilot program for biotechnology submissions, which is intended to help the agency develop guidance on the topic.
